Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Marts 2019

Planlagt Fastgjort Låst Flyttet Genmab
1.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #897

    "And what is also encouraging is that Janssen recently, they also have a BCMA CD3 bispecific program using our DuoBody technology….& said in the business update that they intend to actually combine their BCMA CD3 bispecific together with daratumumab and not compete with daratumumab, and that is probably the right thing to do also for the BCMA ADC from Glaxo and potentially for Amgen's BCMA BiTE molecule."

    1 Reply Last reply
    0
    • P Offline
      P Offline
      peter12
      wrote on sidst redigeret af
      #898

      Det var det EL linkede til i onsdags. Det er et lille studie (n=35) og kun friske patienter, da det nok er for giftigt til svagere...

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #899

        Tak for reminderen E L. 🙂

        1 Reply Last reply
        0
        • G Offline
          G Offline
          gentogen
          wrote on sidst redigeret af
          #900

          Lidt svært helt at gennemskue, men 54% af patienterne var "Stage I" og alle ECOG 0 eller 1 (70% 1). Tidligere behandlinger fra 1 til over 10. 14 en eller anden slags Dara behandling tidligere. Safety lidt svær at vurdere da procenterne er procenter af alle, selv om kun 22 af 35 gennemførte (så tallene kan være for små - måske). De fremhæver selv at dette er det hidtil bedste, der er set efter Dara

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #901

            Link Preview Image
            Genmab Announces European Regulatory Submission for Daratumumab in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma

            Company Announcement Type II variation application submitted to the EMA for daratumumab in combination with lenalidomide and dexamethasone as treatment...

            favicon

            GlobeNewswire News Room (www.globenewswire.com)

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #902

              Genmab Announces European Regulatory Submission for Daratumumab in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma

              1 Reply Last reply
              0
              • S Offline
                S Offline
                Sukkeralf
                wrote on sidst redigeret af
                #903

                Nice

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #904

                  it remains strange to me that there is such a difference between US and european treatment regimen. I wonder if some day we'll see a head-to-head MAIA-Alcyone trial?

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    peter12
                    wrote on sidst redigeret af
                    #905

                    Now you can buy generic Revlimid in some european countries ?

                    1 Reply Last reply
                    0
                    • J Offline
                      J Offline
                      jkj
                      wrote on sidst redigeret af
                      #906

                      Hvornår var det helt præcist at jannsen aflevere sidste data til fda ?

                      1 Reply Last reply
                      0
                      • J Offline
                        J Offline
                        jkj
                        wrote on sidst redigeret af
                        #907

                        herfra skal vi vel regne med 4 uger ifølge rtor planen eller hvad ?

                        1 Reply Last reply
                        0
                        • J Offline
                          J Offline
                          jkj
                          wrote on sidst redigeret af
                          #908

                          det var den 12 marts

                          1 Reply Last reply
                          0
                          • J Offline
                            J Offline
                            jkj
                            wrote on sidst redigeret af
                            #909

                            tvivler på at de er hurtigere end skitseret, så i mellem 8 - 12 april

                            1 Reply Last reply
                            0
                            • J Offline
                              J Offline
                              jkj
                              wrote on sidst redigeret af
                              #910

                              Men Seattle Genetics fik på under 14 dage efter sidst indlevering, så der er da en teoretisk risiko for cognac til kaffen i aften.

                              1 Reply Last reply
                              0
                              • T Offline
                                T Offline
                                Tandfeen-2
                                wrote on sidst redigeret af
                                #911

                                Tror først det bliver efter påske

                                1 Reply Last reply
                                0
                                • Legolas23L Offline
                                  Legolas23L Offline
                                  Legolas23
                                  wrote on sidst redigeret af
                                  #912

                                  Darzalex har slået så mange rekorder, så mon ikke også godkendelsen kommer hurtigere end ventet.

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #913

                                    Talking to The Pharma Letter, Janssen’s EMEA therapy area lead for hematology, Catherine Taylor, said: “I had commissioners coming up to me and telling me that “this is a game changer, this is going to change practice.” https://www.thepharmaletter.com/article/early-oncology-pacesetters-for-2019-will-seek-to-pick-up-where-janssen-left-on-in-2018

                                    1 Reply Last reply
                                    0
                                    • L Offline
                                      L Offline
                                      lahn1
                                      wrote on sidst redigeret af
                                      #914

                                      Nice too 😄

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        polle1
                                        wrote on sidst redigeret af
                                        #915

                                        Flot dag i forhold til resten af markedet idag. God weekend 🙂

                                        1 Reply Last reply
                                        0
                                        • Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktør
                                          wrote on sidst redigeret af
                                          #916

                                          Just a moment...

                                          favicon

                                          (www.proinvestor.com)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger